July 24, 2017 6:13 PM ET


Company Overview of Koronis Pharma, Inc.

Key Executives for Koronis Pharma, Inc.

NameBoard RelationshipsTitleAge
Robert L. Murphy M.D.98 RelationshipsConsulting Chief Medical Director and Clinical & Scientific Advisor--
Donald E. Bergstrom Ph.D.16 RelationshipsClinical and Scientific Advisor--
Joseph J. Eron Jr., M.D.33 RelationshipsMember of Clinical Advisory Board and Clinical & Scientific Advisor--
Daniel R. Kuritzkes M.D.57 RelationshipsMember of Clinical Advisory Board and Clinical and Scientific Advisor--

Koronis Pharma, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Donald J. Elmer 23 RelationshipsPacific Horizon Ventures--
Stephen M. Smith M.D. 21 RelationshipsKoronis Pharma, Inc.--
Douglas D. Richman M.D. 87 RelationshipsChimerix, Inc.--
James I. Mullins Ph.D. 11 RelationshipsKoronis Pharma, Inc.--
Susan J. Little M.D. 11 RelationshipsKoronis Pharma, Inc.--
View All Board Members

Koronis Pharma, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Koronis Pharma, Inc. CEO Compensation
Industry Average


CTI BioPharma Appoints Laurent Fischer to Board of Directors
July 24, 2017 5:30 AM ET
Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer
July 21, 2017 1:28 PM ET
Valens GroWorks Corp. Appoints Saul Katz as President
July 21, 2017 4:19 AM ET
Aeterna Zentaris Inc. Announces Executive Changes
July 20, 2017 9:00 PM ET
Aeglea BioTherapeutics, Inc. Announces Executive Changes
July 20, 2017 8:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Koronis Pharma, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.